English

CORPORATE TRANSACTIONS BY BIOHIT PLC.

Report this content 
BIOHIT PLC.     STOCK EXCHANGE RELEASE   2.1.2001  AT 15:00    1 (1)

CORPORATE TRANSACTIONS BY BIOHIT PLC.


Biohit has sold on Dec. 29, 2000 its majority share, i.e., 51% of  the
U.K.  company Wolf Laboratories, Ltd. The majority share was  acquired
by  the  current  minority shareholders for a purchase  price  of  GBP
165.000.  Wolf Laboratories Ltd. has acted in the U.K., e.g.,  as  the
distributor  of Biohit products as well as other laboratory  products.
The  purpose  of the transaction is to clarify the Group structure  of
Biohit  so  that the Group companies will concentrate  solely  on  the
manufacture  and  sales  of Biohit products. The  net  sales  of  Wolf
Laboratories Ltd. totalled to FIM 16,3 million in 1.1.2000 - 30.9.2000
(FIM  10,6  million during the corresponding period in 1999)  and  the
profit  to FIM 30.000 (FIM 200.000 during the corresponding period  in
1999).  The  financial position of the company has been  satisfactory.
Wolf  Laboratories Ltd. will continue after the transaction,  together
with Biohit Ltd., as the local distributor for Biohit products.

Biohit  Plc.  acquired on Dec. 29, 2000  44% of  the  Russian  company
Finnbio  Ltd.,  which  acts  primarily as the  distributor  of  Biohit
products in Russia and other CIS-countries. The purchase price of  the
shares totalled to USD 99.999. As a result of the acquisition Biohit's
ownership of the shares and votes totals now to 100%. The net sales of
Finnbio Ltd. totalled to FIM  9,5 million  in 1.1.2000 - 30.9.2000 and
the  profit to FIM 0,6 million. The financial position of the  company
is good.

Additional information:    Osmo Suovaniemi,President & CEO
                           Tel: +358-9-773 86 250, mobile: +358-50-556
                           5605, fax: +358-9-773 86 205

                           www.biohit.com

Distribution:              Helsinki Exchanges
                           The Financial Supervisory Authority
                           Press

Subscribe